Assignee
BIOLEGEND INC
US·12 granted patents·20 pending applications·29 citations·filing 2016–2025
Top patents by PatentIndex Score
32 records- 0195US10585088B2Stable nanomagnetic particle dispersionsBIOLEGEND INC·Filed 2016·Granted Mar 10, 2020·13 cites·18 claims
- 0293US11155714B2Substituted polyfluorene compoundsBIOLEGEND INC·Filed 2019·Granted Oct 26, 2021·8 cites·13 claims
- 0391US11584883B2Conjugated polymers and methods of useBIOLEGEND INC·Filed 2019·Granted Feb 21, 2023·4 cites·23 claims
- 0490US11630104B2Stable nanomagnetic particle dispersionsBIOLEGEND INC·Filed 2019·Granted Apr 18, 2023·3 cites·4 claims
- 0589US12091554B2Substituted polyfluorene compoundsBIOLEGEND INC·Filed 2021·Granted Sep 17, 2024·1 cites·12 claims
- 0684US2024360319A1Substituted polyfluorene compoundsBIOLEGEND INC·Filed 2024·Application pending·0 cites
- 0781US12461095B2Stable nanomagnetic particle dispersionsBIOLEGEND INC·Filed 2023·Granted Nov 4, 2025·0 cites·8 claims
- 0879US2025297156A1Conjugated polymers and methods of useBIOLEGEND INC·Filed 2025·Application pending·0 cites
- 0976US12384964B2Conjugated polymers and methods of useBIOLEGEND INC·Filed 2022·Granted Aug 12, 2025·0 cites·15 claims
- 1072US2023272344A1Compositions and methods for performing magnetibuoyant separationsBIOLEGEND INC·Filed 2023·Application pending·0 cites
- 1171US2026043811A1Methods for detecting meteorin-beta activityBIOLEGEND INC·Filed 2025·Application pending·0 cites
- 1271US2026043812A1Methods for detecting meteorin-beta activityBIOLEGEND INC·Filed 2025·Application pending·0 cites
- 1363US2026079168A1Tau phospho (thr217) binding antibodies and antigen binding fragments thereofBIOLEGEND INC·Filed 2025·Application pending·0 cites
- 1462US2025313650A1Chi3l1 binding antibodies and antigen binding fragments thereofBIOLEGEND INC·Filed 2025·Application pending·0 cites
- 1562US2024145035A1Analyzing per-cell co-expression of cellular constituentsBIOLEGEND INC·Filed 2023·Application pending·0 cites
- 1662US2026085128A1Anti-cd157 antibodies, antigen-binding fragments thereof and compositions and methods for making and using the sameBIOLEGEND INC·Filed 2023·Application pending·0 cites
- 1761US2024125806A1Phosphatidylserine binding agents for the detection and depletion of phosphatidylserine positive cellsBIOLEGEND INC·Filed 2023·Application pending·0 cites
- 1859US2026042848A1Anti-axl antibodies, antigen-binding fragments thereof and methods for making and using the sameBIOLEGEND INC·Filed 2023·Application pending·0 cites
- 1958US11608489B2Compositions and methods for performing magnetibuoyant separationsBIOLEGEND INC·Filed 2017·Granted Mar 21, 2023·0 cites·14 claims
- 2057US12455290B2Methods for detecting meteorin-β activityBIOLEGEND INC·Filed 2021·Granted Oct 28, 2025·0 cites·15 claims
- 2156US2025226059A1Visualizing intra-cell co-expression of cellular constituents using dimensionality reduction that is weighted by cell typeBIOLEGEND INC·Filed 2025·Application pending·0 cites
- 2256US2025052767A1Cd28 binding antibodies and antigen binding fragments thereofBIOLEGEND INC·Filed 2022·Application pending·0 cites
- 2353US2025382358A1Methods and compositions relating to mouse monoclonal anti-g4s linker antibodiesBIOLEGEND INC·Filed 2025·Application pending·0 cites
- 2451US2023193246A1Methods and compositions for detecting targetsBIOLEGEND INC·Filed 2021·Application pending·0 cites
- 2546US2024360228A1Anti-ccr8 antibodies, antigen-binding fragments thereof, and agents and compositions and methods for making and using the sameBIOLEGEND INC·Filed 2022·Application pending·0 cites
- 2645US2023054169A1Anti-tlr7 agents and compositions and methods for making and using the sameBIOLEGEND INC·Filed 2022·Application pending·0 cites
- 2744US2025093339A1Compositions and methods for enhanced sample multiplexingBIOLEGEND INC·Filed 2022·Application pending·0 cites
- 2842US2025341514A1Compositions for use with multiple fluorophores and methods of usingBIOLEGEND INC·Filed 2025·Application pending·0 cites
- 2942US2025341516A1Compositions for use with multiple fluorophores and methods of usingBIOLEGEND INC·Filed 2025·Application pending·0 cites
- 3040US12590973B2Uses of IL-40 and methods for detecting IL-40 activityBIOLEGEND INC·Filed 2021·Granted Mar 31, 2026·0 cites·17 claims
- 3140US12006363B2Anti-tetraspanin 33 agents and compositions and methods for making and using the sameBIOLEGEND INC·Filed 2020·Granted Jun 11, 2024·0 cites·9 claims
- 3239US12441806B2Anti-TLR9 agents and compositions and methods for making and using the sameBIOLEGEND INC·Filed 2021·Granted Oct 14, 2025·0 cites·5 claims
Join the waitlist — get patent alerts
Get an alert when BIOLEGEND INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →